WinstonWınston
Back

Deep Value: cash covers more than 100% of the stock price

This company holds roughly $16,743 in cash and investments — more than its entire stock-market value, based on its latest quarterly filing. You're paying very little for the actual business. Sometimes that's a genuine bargain or a takeover target, sometimes it's cheap for a reason. Not a buy signal on its own — always ask why it's this cheap.

Bespoke Extracts logo

Bespoke Extracts

BSPK
Drug Manufacturers - Specialty & Generic · Healthcare
Price
$0.00
+0.00 (+28.57%)
Market Cap
$10,128
Winston Score
Winston looking sleepy
No score yet — Winston is napping.
We couldn’t gather enough financial data to score this stock reliably.

Share count rising — dilution

+681.9% over 5y

The company has issued more shares over this period, which dilutes each existing shareholder’s stake.

Diluted shares outstanding: 1.3M (2019) → 10.5M (2024)

Winston Score History

The full picture

Bespoke Extracts is a small cannabis company that makes hemp-derived CBD products. Its main products include CBD tinctures, gummies, and other wellness supplements sold directly to consumers and through retail partners. The company operates in the legal hemp market, which was opened up in the United States after the 2018 Farm Bill made hemp-derived CBD federally legal.

The company earns revenue primarily through direct-to-consumer online sales and wholesale distribution to retailers. It operates mainly in the United States and is a very small player in a crowded CBD market with hundreds of competing brands. The operating margin is deeply negative, meaning the company spends far more than it earns, which is a serious financial risk. The biggest challenge ahead is standing out in an oversaturated market while managing cash burn, as many small CBD companies have struggled to survive without a clear brand advantage or path to profitability.

Growth Profile

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

YoY Growth Rate

Revenue data limited

EPS Growth

YoY Growth Rate

EPS data limited

R&D Spend

$0/ year

0.0% of revenue

Below sector average (18%)

Research and development spending

Insider Activity

40.3%ownership

Flat

Insider ownership roughly steady over the past year

Cash Runway

~3 months

$16,743 cash & investments

Quarterly Free Cash Flow

Short runway — potential dilution ahead through share issuance

Cash watch

Bespoke Extracts has less than a year of cash at its current burn rate. Growth investors should watch for potential share dilution from future fundraising — that directly reduces your ownership.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale
Gross Margin
50.0%
Healthy — 50.0% gross margin
Profit after running costs
Operating Margin
-11.5%
Losing money on operations — -11.5%
Return on the money invested
ROCE
N/A
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth
Sales YoY
N/A
Data not available
Profit growth
EPS YoY
N/A
Data not available
How steady the profit is
EPS Consistency
6/8 quarters
Earnings grew in most of the last 8 quarters

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash
Cash Conversion
N/A
Data not available
Spare cash per sale
FCF Margin
-19.2%
Burning cash (-19.2%)

Free cash flow is negative. They are burning cash, not generating it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns
Debt / Equity
N/A
Data not available
Covers its interest
Interest Cover
N/A
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit
P/E Ratio (TTM)
N/M
Negative earnings — P/E not meaningful
Cheaper or dearer next year
P/E vs Forward
N/A
not available
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial